Silke is a seasoned regulatory professional with > 15 years of experience in pharmaceutical industry. Since 2011, she has been heading Grünenthal’s Global Regulatory Affairs team and is as such accountable for all regulatory matters worldwide related to Grünenthal’s product portfolio and its pipeline. In her role as Head Global Regulatory Affairs, Silke is a core member of Grünenthal’s R&D Leadership Team and relevant decision boards. Silke has a strong background in EU and US regulatory affairs with a track record of successfully supporting the development / optimization of clinical development plans and leading scientific negotiations with regulatory health authorities (e.g. EMA, national EU authorities and FDA).